Position
Squarepoint Ops LLC in Royalty Pharma PLC
Back to the book · All holders of RPRX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $12.6M$38.64 → $47.97
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.56M | $60.1M | — | — | — | 0.1% |
| Q1 2026 | 1.35M | $64.7M | $47.97 | $12.6M | −$7.99M | 0.1% |